Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1579
Biochemistry & Physiology: Open Access received 1579 citations as per Google Scholar report
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- Ulrich's Periodicals Directory
- Electronic Journals Library
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Scholarsteer
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Kevin Charles Kemp
Biography
Kevin Kemp is a researcher within the School of Clinical Neurosciences at the University of Bristol, UK. He obtained his first degree in Biomedical Sciences at the University of the West of England in 2003, where he went on to receive a PhD in 2007. Prior to his PhD studies Dr Kemp received a distinction for his Masters degree in Transfusion and Transplantation Sciences at the University of Bristol. As a senior post-doctoral scientist at the Multiple Sclerosis and Stem Cell laboratories, University of Bristol, his research interests are now in the therapeutic use of stem cells for neurodegenerative disorders, an area in which he has published many scientific research papers. Dr Kemp has a major role in supervising post-graduate students and clinical research fellows. He has also set up a number of research collaborations through close liaison with researchers from the around the world.
Research Interest
He aims to explore new treatments for patients with degenerative ataxias and other neurodegenerative disorders. His research involves investigating the potential of mobilisation (drug induced or transplantation) of human bone marrow-derived stem cells and/or other stem cell populations to promote neuronal cell survival and regeneration.
Certificate
